LOVD - Variant listings for RPS19

About this overview [Show]

Patient data (#0000116)
Patient ID pat1rps1900045
Gender f
Malformations None
Growth Retardation na
Steroid Response na
Complications -
Variant Origin familial
Reference Matsson et al (1999) Hum Genet 105, 496-500
Template DNA
Technique SEQ, Southern
Remarks -
# Reported 1

Variant data
Allele Paternal (confirmed)
Reported pathogenicity Pathogenic
Concluded pathogenicity Pathogenic
Exon 03
DNA change c.[134_135delinsAA;139_140insTC]   (View in UCSC Genome Browser, Ensembl)
RNA change -
Protein p.[Leu45Gln;Pro47LeufsX30]
Frequency -
DB-ID RPS19_00045
Location -
Remarks Insertion/Deletion
Molecula Mechanisms -
Functional_Classific Unclassified
mRNA_Expression Levels similar to controls could exclude NMD (BM CD34+ and PB MNC) [1]
Protein_Expression -
Protein_Localization -
rRNA_Metabolism 18S rRNA processing defect, as indicated by increase in 21S pre-rRNA (21S/18SE ratio:3,8) (BM CD34- cells) [2]
Protein_Synthesis -
Cell_Growth -
Functional_Remarks -
Functional_Reference [1] Hamaguchi et al (2002) Blood 100, 2724-31; [2] Flygare et al (2007) Blood 109, 980-6

1 entry in RPS19

Path.
Allele Descending
Ascending
Exon Descending
Ascending
DNA change Descending
Ascending
RNA change Descending
Ascending
Protein Descending
Ascending
Frequency Descending
Ascending
DB-ID Descending
Ascending
Location Descending
Ascending
Remarks Descending
Ascending
Molecula Mechanisms Descending
Ascending
Functional_Classific Descending
Ascending
mRNA_Expression Descending
Ascending
Protein_Expression Descending
Ascending
Protein_Localization Descending
Ascending
rRNA_Metabolism Descending
Ascending
Protein_Synthesis Descending
Ascending
Cell_Growth Descending
Ascending
Functional_Remarks Descending
Ascending
Functional_Reference Descending
Ascending
+/+ Paternal (confirmed) 03 c.[134_135delinsAA;139_140insTC] - p.[Leu45Gln;Pro47LeufsX30] - RPS19_00045 - Insertion/Deletion - Unclassified Levels similar to controls could exclude NMD (BM CD34+ and PB MNC) [1] - - 18S rRNA processing defect, as indicated by increase in 21S pre-rRNA (21S/18SE ratio:3,8) (BM CD34- cells) [2] - - - [1] Hamaguchi et al (2002) Blood 100, 2724-31; [2] Flygare et al (2007) Blood 109, 980-6